Omkar Speciality Chemicals share news and announcements

BSE: 533317Chemicals & Petrochemicals

Trading suspended since 29 Apr 2026

Last traded ₹3.41 on 28 Apr 2026

Omkar Speciality Chemicals share news and announcements

1,242 announcements, routine notices left out, newest first. Page 10 of 25.

May 2018
- 18 May · Board meeting
  Outcome of Board Meeting held on May 18, 2018. (opens in a new tab)
- 18 May · Announcement Under Regulation 30 Of LODR-Updates
  We wish to inform you that the Board of Directors .... (opens in a new tab)
Apr 2018
- 18 Apr · Compliance Certificate For The Period Ended March 31, 2018
  Compliance Certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 16 Apr · Updates
  The Resource Committee Meeting of the Company was held on April 16, 2018. The members ofthe committee discussed the matter regarding Bank of Baroda having declared the LoanAccount of the Company as Non-Performing Asset. The members discussed in length and theCompany is working on a suitable solution to address this matter. (opens in a new tab)
- 16 Apr · Announcement Under Regulation 30 Of The SEBI (LODR)-Updates
  Classification of Loan Account of the Company as Non-Performing Asset by Bank. (opens in a new tab)
- 16 Apr · HALF YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY
  We are enclosing herewith Certificate for the half year ended March 31, 2018 .... (opens in a new tab)
- 16 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 16 Apr · Shareholding for the Period Ended March 31, 2018
  Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....
- 7 Apr · Disclosure
  Pravin S. Herlekar has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Mar 2018
- 8 Mar · Announcement under Regulation 30 (LODR)-Updates
  FILING OF A PATENT APPLICATION. (opens in a new tab)
- 8 Mar · Updates
  FILING OF A PATENT APPLICATION (opens in a new tab)
Feb 2018
- 20 Feb · Announcement under Regulation 30 (LODR)-Updates
  Intimation as per Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 20 Feb · Disclosure
  Vide letter dated February 20, 2018 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 19 Feb · Legal
  Exchange had sought clarification from Omkar Speciality Chemicals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Standalone limited review report not submitted. -2. Segment details not submitted. The response of the Company is enclosed. (opens in a new tab)
- 15 Feb · Disclosure
  Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Omkar P Herlekar (opens in a new tab)
- 12 Feb · Legal
  Exchange has sought clarification from Omkar Speciality Chemicals Limited for financial results submitted for quarter ended September 30, 2017, with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted. The response of the Company is enclosed. (opens in a new tab)
- 12 Feb · Business
  PRESS RELEASE (opens in a new tab)
- 12 Feb · Business
  Press release dated February 12, 2018, titled "PRESS RELEASE REG. 30". (opens in a new tab)
- 9 Feb · Disclosure
  Vide letter dated February 09, 2018 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 9 Feb · Legal
  Exchange had sought clarification from Omkar Speciality Chemicals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Reconciliation of profit and loss not submitted. The response of the Company is enclosed. (opens in a new tab)
- 9 Feb · Announcement under Regulation 30 (LODR)-Updates
  Intimation as per Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (opens in a new tab)
- 6 Feb · Results
  Reconciliation Table for net profit / loss of the Company for the quarter ended June 30, 2017. (opens in a new tab)
- 6 Feb · Legal
  Exchange has sought clarification from Omkar Speciality Chemicals Limited for financial results submitted for quarter ended December 31, 2017, with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone limited review report not submitted. -2. Segment details not submitted. The response of the Company is awaited.
- 6 Feb · Legal
  Exchange has sought clarification from Omkar Speciality Chemicals Limited for financial results submitted for quarter ended September 30, 2017, with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted. The response of the Company is awaited.
- 6 Feb · Updates
  Please find attached herewith revised outcome of Board meeting held on February 05, 2018 for the Quarter ended December 31, 2017 (opens in a new tab)
- 6 Feb · Results
  Revised Standalone Financial Results for the period ended December 31, 2017 (opens in a new tab)
- 5 Feb · Results
  Financial results for the period ended December 31, 2017. (opens in a new tab)
- 5 Feb · Board meeting
  Outcome of Board meeting held today for the quarter and nine months ended December 31, 2017 (opens in a new tab)
- 5 Feb · Results
  Financial results for the period ended September 30, 2017. (opens in a new tab)
- 5 Feb · Board meeting
  Outcome of Board Meeting held today for Unaudited Financial Results for the quarter and half year ended September 30, 2017. (opens in a new tab)
Jan 2018
- 29 Jan · Updates
  Grant of Patent (opens in a new tab)
- 29 Jan · Updates
  GRANT OF PATENT FOR "PROCESS FOR PREPARATION OF ALKALI METAL IODIDE" (opens in a new tab)
- 16 Jan · Shareholding for the Period Ended December 31, 2017
  Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....
- 15 Jan · Board meeting
  05-Feb-2018 : The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held December 14, 2017, Inter alia to consider and take on record the following matter: 1. To consider, approve and take on record the Unaudited Financial Results for quarter and half year ended on September 30, 2017 and to take note of the Limited Review Report thereon. 2. To discuss any other matter incidental thereto. The Company has now informed the Exchange that the meeting of the Board of Directors will be held on February 05, 2018, inter alia to consider and take on record the following matter: 1. To consider, approve and take on record the Unaudited Financial Results for quarter and half year ended on September 30, 2017 and to take note of the Limited Review Report thereon. 2. To discuss any other matter incidental thereto. (opens in a new tab)
  Not held on this date
- 15 Jan · Board Meeting On February 05, 2018
  INTIMATION OF THE BOARD MEETING. (opens in a new tab)
- 15 Jan · Board Meeting Rescheduled
  INTIMATION FOR RESCHEDULING OF THE BOARD MEETING. (opens in a new tab)
- 11 Jan
  Statement Of Investor Complaints For The Quarter Ended December 31, 2017. (opens in a new tab)
- 8 Jan · Updates
  Declaration pursuant to Regulation 31(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (opens in a new tab)
- 8 Jan · Disclosure
  Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravin S Herlekar (opens in a new tab)
- 8 Jan · Disclosure
  Pravin S. Herlekar has submitted to the Exchange Regulation 10(6) Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a)(i) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 respect of acquisition under Regulation 10(1)(a)(i) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (opens in a new tab)
- 8 Jan · Updates
  Intimation as per Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 8 Jan · Disclosure
  Vide letter dated January 03, 2018 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 2 Jan · Updates
  Disclosure under Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (opens in a new tab)
Dec 2017